Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan M Seddon

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Standards in Genomic Sciences|February 7, 2017
Potential probiotic-associated traits revealed from completed high quality genome sequence of <i>Lactobacillus fermentum</i> 3872Burhan Lehri, Alan M Seddon, Andrey V Karlyshev
BMC Microbiology|June 3, 2014
A negative effect of Campylobacter capsule on bacterial interaction with an analogue of a host cell receptorSona Rubinchik, Alan M Seddon, Andrey V Karlyshev
Microbiology (Reading, England)|March 12, 2015
Campylobacter-Acanthamoeba interactionsAna Vieira, Alan M Seddon, Andrey V Karlyshev
International Journal of Oncology|September 8, 2016
Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugsSoozana Puvanenthiran, Sharadah Essapen, Alan M Seddon, et al.
International Journal of Oncology|May 28, 2011
Growth response of human colorectal tumour cell lines to treatment with afatinib (BIBW2992), an irreversible erbB family blocker, and its association with expression of HER family membersSaid Abdullah Khelwatty, Sharadah Essapen, Alan M Seddon, et al.
Scientific Reports|June 23, 2017
Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell linesAryan Stanley, G Hossein Ashrafi, Alan M Seddon, et al.
Applied and Environmental Microbiology|September 17, 2017
CmeABC Multidrug Efflux Pump Contributes to Antibiotic Resistance and Promotes Campylobacter jejuni Survival and Multiplication in Acanthamoeba polyphagaAna Vieira, Amritha Ramesh, Alan M Seddon, et al.
BMC Cancer|February 2, 2013
Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cellsNikolaos Ioannou, Alan M Seddon, Angus Dalgleish, et al.
Frontiers in Bioscience (Landmark Edition)|June 2, 2012
Expression pattern and targeting of HER family members and IGF-IR in pancreatic cancerNikolaos Ioannou, Alan M Seddon, Angus Dalgleish, et al.
British Journal of Cancer|September 16, 2015
Acquired resistance to anti-EGFR mAb ICR62 in cancer cells is accompanied by an increased EGFR expression, HER-2/HER-3 signalling and sensitivity to pan HER blockersSaid A Khelwatty, Sharadah Essapen, Alan M Seddon, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Standards in Genomic Sciences|February 7, 2017
Potential probiotic-associated traits revealed from completed high quality genome sequence of <i>Lactobacillus fermentum</i> 3872Burhan Lehri, Alan M Seddon, Andrey V Karlyshev
BMC Microbiology|June 3, 2014
A negative effect of Campylobacter capsule on bacterial interaction with an analogue of a host cell receptorSona Rubinchik, Alan M Seddon, Andrey V Karlyshev
Microbiology (Reading, England)|March 12, 2015
Campylobacter-Acanthamoeba interactionsAna Vieira, Alan M Seddon, Andrey V Karlyshev
International Journal of Oncology|September 8, 2016
Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugsSoozana Puvanenthiran, Sharadah Essapen, Alan M Seddon, et al.
International Journal of Oncology|May 28, 2011
Growth response of human colorectal tumour cell lines to treatment with afatinib (BIBW2992), an irreversible erbB family blocker, and its association with expression of HER family membersSaid Abdullah Khelwatty, Sharadah Essapen, Alan M Seddon, et al.
Scientific Reports|June 23, 2017
Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell linesAryan Stanley, G Hossein Ashrafi, Alan M Seddon, et al.
Applied and Environmental Microbiology|September 17, 2017
CmeABC Multidrug Efflux Pump Contributes to Antibiotic Resistance and Promotes Campylobacter jejuni Survival and Multiplication in Acanthamoeba polyphagaAna Vieira, Amritha Ramesh, Alan M Seddon, et al.
BMC Cancer|February 2, 2013
Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cellsNikolaos Ioannou, Alan M Seddon, Angus Dalgleish, et al.
Frontiers in Bioscience (Landmark Edition)|June 2, 2012
Expression pattern and targeting of HER family members and IGF-IR in pancreatic cancerNikolaos Ioannou, Alan M Seddon, Angus Dalgleish, et al.
British Journal of Cancer|September 16, 2015
Acquired resistance to anti-EGFR mAb ICR62 in cancer cells is accompanied by an increased EGFR expression, HER-2/HER-3 signalling and sensitivity to pan HER blockersSaid A Khelwatty, Sharadah Essapen, Alan M Seddon, et al.
Pageof 3